T2	total-participants 294 304	Twenty-six
T3	eligibility 305 343	women with nonmetastatic breast cancer
T4	intervention-participants 406 408	15
T6	age 419 435	51.9 ± 9.8 years
T7	control 445 458	control group
T9	age 477 493	56.9 ± 7.0 years
T8	control-participants 464 466	11
T12	outcome 879 888	endurance
T13	outcome 933 953	strength performance
T14	outcome 1004 1019	quality of life
T15	outcome 1077 1091	adverse events
T5	intervention 47 88	high-intensity interval/strength training
